Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
We have previously identified substantial antibiotic treatment heterogeneity, even among organism-specific and site-specific infections with treatment guidelines. Therefore, we sought to quantify the extent of treatment heterogeneity among patients hospitalized with <i>P. aeruginosa</i>...
Saved in:
Main Authors: | Aisling R. Caffrey (Author), Haley J. Appaneal (Author), J. Xin Liao (Author), Emily C. Piehl (Author), Vrishali Lopes (Author), Laura A. Puzniak (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant <i>Pseudomonas aeruginosa</i> Infections
by: Aisling R. Caffrey, et al.
Published: (2022) -
Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses
by: Haley J. Appaneal, et al.
Published: (2023) -
<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021) -
Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022) -
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021)